# Eric Verdin, MD, PhD

> Eric M. Verdin is a Belgian-born scientist, president and CEO of the Buck Institute for Research on Aging, a professor at the University of California, San Francisco, and a co-founder of Circulate Health. He joined the Buck in 2016 after a long career at Gladstone and combines laboratory research with institutional leadership, company formation and scientific advisory work. Outside the institute, he races karts.

- **Role:** President and Chief Executive Officer at the Buck Institute for Research on Aging; Co-founder at Circulate Health
- **Organizations:** Buck Institute for Research on Aging, Circulate Health, University of California, San Francisco, Gladstone Institutes, Attilio, Acylin, National Institutes of Health, University of Brussels, Picower Institute for Medical Research
- **Nationality:** Belgian
- **Education:** Doctor of Medicine (MD), University of Liège, Additional clinical and research training, Harvard Medical School
- **Known for:** The Buck laboratory biography credits him with more than 270 scientific papers and more than 18 patents; those figures are undated lower bounds., Recipient of a Glenn Award for Research in Biological Mechanisms of Aging., Recipient of a senior scholarship from the Ellison Medical Foundation.

## Career timeline

- **1997** — Joined Gladstone, according to his public biography.
- **2004-2016** — Served as associate director at Gladstone.
- **2016** — Named president and CEO of the Buck on November 18; trustees announced $10 million in pledged gifts at the same time.
- **2019** — Joined the National Academy of Medicine president’s advisory council for its global grand challenge.
- **2025** — Appeared as a witness before the U.S. Senate Special Committee on Aging on February 12.
- **2026** — Attilio announced his appointment as co-chairman on October 16.

## Achievements

- The Buck laboratory biography credits him with more than 270 scientific papers and more than 18 patents; those figures are undated lower bounds.
- Recipient of a Glenn Award for Research in Biological Mechanisms of Aging.
- Recipient of a senior scholarship from the Ellison Medical Foundation.
- Elected fellow of the American Association for the Advancement of Science.
- Elected member of the American Society for Clinical Investigation and Association of American Physicians.
- Founder of Acylin, which the Buck biography says was purchased by AbbVie.
- Co-founder of Circulate Health alongside Brad Younggren.

## Latest updates

- **2026-10** — Attilio announced Verdin as co-chairman on October 16 and listed him for its October 29-30 inaugural event.
- **2026-08** — Verdin welcomed Lisa Seitz Gruwell as the Buck’s chief advancement officer in an August 13 announcement.
- **2026-07** — The Buck announced a biological AI safety partnership with Fennec Engineering, led by faculty member James Yurkovich.

## Links

- Website: https://www.buckinstitute.org/lab/verdin-lab/
- LinkedIn: https://www.linkedin.com/in/eric-verdin-490212
- Twitter/X: https://x.com/EricVerdin
- Instagram: https://www.instagram.com/ericverdinmd

---

Profile page: https://yespress.io/eric-verdin
Published by YesPress — https://yespress.io
Last updated: 2026-10-21